Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi - 10 Feb 2026

Li J L, Hao J J, Hu J, Song C, Wang D, Zhang Z C, Ruan Y H, Feng Y, Liao L J, Xing H

Abstract excerpt

Objective: To understand the drug resistance characteristics of rilpivirine (RPV) in HIV-1-infected patients before starting antiretroviral therapy (ART) in nine provinces of China. Methods: A cross-sectional study design was adopted by probability proportional to size(PPS) sampling. Nine provinces (Hebei, Jilin, Jiangsu, Zhejiang, Hubei, Chongqing, Sichuan, Yunnan and Xinjiang) were selected as the research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Rilpivirine

Share to Young Adult

Source

Identifiers

PMID: 41765666
DOI: 10.3760/cma.j.cn112338-20250802-00550

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China].PMID 41765666Read ↗

Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China.Semantic proximity Read ↗

Characterization of Pretreatment Drug Resistance among people living with HIV from 2018 to 2022 in Guangzhou, ChinaSemantic proximity Read ↗

Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.Semantic proximity Read ↗

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read ↗

Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.Semantic proximity Read ↗

Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018–2022Semantic proximity Read ↗

Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, China.Semantic proximity Read ↗

Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-naïve HIV patients.Semantic proximity Read ↗

Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.Semantic proximity Read ↗

Prevalence and transmission of HIV-1 drug resistance mutations among patients with treatment failure and newly diagnosed people in Liangshan Prefecture, China, in 2021–2023Semantic proximity Read ↗

Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.Semantic proximity Read ↗

HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.